ACR Highlights Imaging Payment Changes in HOPPS Final Rule
ACR outlines key radiology updates in CMS 2026 HOPPS final rule, including payment changes and quality reporting updates effective Jan. 1.
Read moreMain Content
ACR Supports Per-Day Threshold in the 2025 HOPPS Rule
Sept. 11, 2024
The American College of Radiology® (ACR®) submitted comments to the Centers for Medicare and Medicaid Services (CMS) related to the calendar year (CY) 2025 Hospital Outpatient Prospective Payment System (HOPPS) proposed rule that address radiology-specific issues and make specific recommendations.
The letter outlines support for the rule’s proposed per-day threshold of $630 to separately pay for diagnostic radiopharmaceuticals but recommends that CMS move toward using Average Sales Price (ASP) to set future years’ calculations for more accurate reimbursement.
The College also lays out potential strategies for CMS to make updates to increase HOPPS payments for CT colonography screening services, which are proposed to be covered via the 2025 Medicare Physician Fee Schedule proposed rule.
CMS will take the comments from stakeholders into consideration and release the final HOPPS rule this November. If finalized, these policies will take effect Jan 1.
If you have questions about the ACR’s HOPPS proposed rule comments, contact Kimberly Greck, ACR Senior Economic Policy Analyst.
The letter outlines support for the rule’s proposed per-day threshold of $630 to separately pay for diagnostic radiopharmaceuticals but recommends that CMS move toward using Average Sales Price (ASP) to set future years’ calculations for more accurate reimbursement.
The College also lays out potential strategies for CMS to make updates to increase HOPPS payments for CT colonography screening services, which are proposed to be covered via the 2025 Medicare Physician Fee Schedule proposed rule.
CMS will take the comments from stakeholders into consideration and release the final HOPPS rule this November. If finalized, these policies will take effect Jan 1.
If you have questions about the ACR’s HOPPS proposed rule comments, contact Kimberly Greck, ACR Senior Economic Policy Analyst.
Related ACR News
ACR Provides Input to FDA on AI Measurement and Evaluation
ACR submitted comments to FDA on real-world AI device performance, stressing safety, governance, and continuous monitoring.
Read moreRadiology’s Fight Against Prior Authorization Delays
ACR is leading national efforts to make prior authorization more efficient and clinically appropriate while reducing the administrative burden and supporting national legislation.
Read more